Conditioned medium of estrogen-treated osteoblasts inhibits osteoclast maturation and function in vitro

Bone

Volumn 25, Issue 2, 1999, Pages 211-215

  Qu, Q ^a   Harkonen P L ^a   Monkkonen J ^b   Vaananen H K ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Bone marrow cells; Conditioned medium; Cytokines; Estrogen; Osteoblast; Osteoclast

Indexed keywords

CYTOKINE; ESTRADIOL; INTERLEUKIN 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BONE MARROW; BONE MASS; BONE TURNOVER; CELL DIFFERENTIATION; CELL MATURATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS;

ACID PHOSPHATASE; ANIMALS; ANIMALS, NEWBORN; BONE MARROW CELLS; CATTLE; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; ESTRADIOL; FEMALE; INTERLEUKIN-1; INTERLEUKIN-6; ISOENZYMES; MICE; OSTEOBLASTS; OSTEOCLASTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0344654964     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(99)00153-2     Document Type: Article

References (36)

1. Arnett T.R., Lindsay R., Kilb J.M., Moonga B.S., Spowage M., Dempster D.W. Selective toxic effects of tamoxifen on osteoclasts Comparison with the effects of oestrogen . J Endocrinol. 149:1996;503-508.
2. Bertolini D.R., Nedwin G.E., Bringman T.S., Smith D.D., Mundy G.R. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature. 319:1986;516-518.
3. Cohen-Solal M.E., Graulet A.M., Denne M.A., Gueris J., Baylink D., de Vernejoul M.C. Peripheral monocyte culture supernatants of menopausal women can induce bone resorption Involvement of cytokines . J Clin Endocrinol Metab. 77:1993;1648-1653.
4. Ettinger B., Genant H.K., Cann C.E. Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med. 102:1985;319-324.
5. Girasole G., Jilka R.L., Passeri G., et al. 17β-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro A potential mechanism for the antiosteoporotic effect of estrogens . J Clin Invest. 89:1992;883-891.
6. Gowen M., Wood D.D., Ihrie E.J., McGuire M.K.B., Russell R.G.G. An interleukin-1-like factor stimulates bone resorption in vitro. Nature. 306:1983;378-380.
7. Ishii T., Saito T., Morimoto K., et al. Estrogen stimulates the elaboration of cell/matrix surface-associated inhibitory factor of osteoclastic bone resorption from osteoblastic cells. Biochem Biophys Res Commun. 191:1993;495-502.
8. Ishimi Y., Miyaura C., Jin C., et al. IL-6 is produced by osteoblasts and induces bone resorption. J Immunol. 145:1990;3297-3303.
9. Jilka R.L., Hangoc G., Girasole G., et al. Increased osteoclast development after estrogen loss Mediation by interleukin-6 . Science. 257:1992;88-91.
10. Kahn A.J., Simmons D.J. Investigation of the cell lineage in bone using a chimera of chick and quail embryonic tissue. Nature. 258:1975;325-327.
11. Kameda T., Mano H., Yuasa T., et al. Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts. J Exp Med. 186:1997;489-495.
12. Kurihara N., Civin C., Roodman G.D. Osteotropic factor responsiveness of highly purified populations of early and late precursors for human multinucleated cells expression the osteoclast phenotype. J Bone Miner Res. 6:1991;257-261.
13. Lakkakorpi P., Tuukkanen J., Hentunen T., Jarvelin K., Väänänen K. Organisation of osteoclast microfilaments during the attachment to bone surface in vitro. J Bone Miner Res. 4:1989;817-825.
14. Lindsay R., Hart D.M., Aitken J.M., McKonald E.B., Anderson J.B., Clarke A.C. Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment. Lancet. 1:1976;1038-1041.
15. Mano H., Yuasa T., Kameda T., et al. Mammalian mature osteoclasts as estrogen target cells. Biochem Biophys Res Commun. 223:1996;637-642.
16. Marks S.C.J., Mackay C.A., Jackson M.E., Larson E.K., Cielinski M.J., Stanley E.R., Aukerman S.L. The skeletal effects of colony-stimulating factor-1 in toothless (osteopetrotic) rats Perisistent metaphyseal sclerosis and the failure to restore subepiphyseal osteoclasts . Bone. 14:1993;675-680.
17. Oursler M.J., Pederson L., Fitzpatrick L., Riggs B.L., Spelsberg T. Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells. Proc Natl Acad Sci USA. 91:1994;5227-5231.
18. Pacifici R., Brown C., Rifas L., Avioli L.V. TNFα and GM-CSF secretion from human blood monocytes Effect of menopause and estrogen replacement . J Bone Miner Res. 5:1990;145.
19. Pacifici R., Rifas L., McCracken R., et al. Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin-1 release. Proc Natl Acad Sci USA. 86:1989;2398-2402.
20. Pacifici R., Rifas L., Teitelbaum S., et al. Spontaneous release of interleukin 1 from human blood monocytes reflects bone formation in idiopathic osteoporosis. Proc Natl Acad Sci USA. 84:1987;4616-4620.
21. Passeri G., Girasole G., Jilka R.L., Manolagas S.C. Increased interleukin-6 production by murine bone marrow and bone cells after estrogen withdrawal. Endocrinology. 133:1993;822-828.
22. Pennanen N., Lapinjoki S., Palander A., Urtti A., Mönkkönen J. Macrophage-like RAW 264 cell line and time-resolved fluoroimmunoassay (TRFIA) as tools in screening drug effects on cytokine secretion. Int J Immunopharmacol. 17:1995;475-480.
23. Pfeilschifter J., Chenu C., Bird A., Mundy G.R., Roodman G.D. Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclast-like cells in vitro. J Bone Miner Res. 4:1989;113-118.
24. Piper K., Boyde A., Jones S.J. The relationship between the number of nuclei of an osteoclast and its resorptive capability in vitro. Anat Embryol. 186:1992;291-299.
25. Qu Q., Perälä-Heape M., Kapanen A., et al. Estrogen enhances differentiation of osteoblasts in mouse bone marrow culture. Bone. 22:1998;201-209.
26. Rodan G.A., Martin T.J. Role of osteoblasts in hormonal control of bone resorption - a hypothesis. Calcif Tissue Int. 34:1982;331-332.
27. Selander K., Lehenkari P., Väänänen H.K. The effects of bisphonates on the resorption cycle of isolated osteoclasts. Calcif Tissue Int. 55:1994;368-375.
28. Simonet W.S., Lacey D.L., Dunstan C.R., et al. Osteoprotegerin A novel secreted protein involved in the regulation of bone density . Cell. 89:1997;309-319.
29. Takahashi N., Udagawa N., Adatsu T., Tanaka H., Shionome M., Suda T. Role of colony-stimulating factors in osteoclast development. J Bone Miner Res. 6:1991;977-985.
30. Tamura T., Takahashi N., Akatsu T., et al. New resorption assay with mouse osteoclast-like multinucleated cells formed in vitro. J Bone Miner Res. 8:1993;953-960.
31. Tamura T., Udagawa N., Takahashi N., et al. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin-6. Proc Natl Acad Sci USA. 90:1993;11924-11928.
32. Thomson B.M., Mundy G.R., Chambers T.J. Tumor necrosis factors α and β induce osteoblastic cells to stimulate osteoclastic bone resorption. J Immunol. 138:1987;775-779.
33. Tobias J.H., Chambers T.J. The effect of sex hormones on bone resorption by rat osteoclasts. Acta Endocrinol. 124:1991;121-127.
34. Van Snick. Interleukin-6 An overview . Annu Rev Immunol. 8:1990;253-278.
35. Walker D.G. Control of bone resorption by hematopoietic tissue. The induction and reversal of congenital osteopetrosis in mice through the use of bone marrow mononuclear phagocytes. J Exp Med. 156:1975;1604-1614.
36. Yasuda H., Shima N., Nakagawa N., et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA. 95:1998;3597-3602.